At the time of writing, Syndax Pharmaceuticals Inc [SNDX] stock is trading at $22.57, up 6.81%. An important factor to consider is whether the stock is rising or falling in short-term value. The SNDX shares have gain 4.83% over the last week, with a monthly amount glided 16.34%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Syndax Pharmaceuticals Inc [NASDAQ: SNDX] stock has seen the most recent analyst activity on June 28, 2024, when Jefferies initiated its Buy rating and assigned the stock a price target of $37. Previously, Scotiabank downgraded its rating to Sector Perform on January 31, 2024, and dropped its price target to $23. On December 22, 2023, Mizuho initiated with a Buy rating and assigned a price target of $45 on the stock. BofA Securities started tracking the stock assigning a Buy rating and suggested a price target of $29 on October 25, 2023. Goldman initiated its recommendation with a Buy and recommended $30 as its price target on October 11, 2023. In a note dated July 11, 2023, Guggenheim initiated an Buy rating and provided a target price of $40 on this stock.
For the past year, the stock price of Syndax Pharmaceuticals Inc fluctuated between $11.22 and $25.34. Currently, Wall Street analysts expect the stock to reach $38 within the next 12 months. Syndax Pharmaceuticals Inc [NASDAQ: SNDX] shares were valued at $22.57 at the most recent close of the market. An investor can expect a potential return of 68.37% based on the average SNDX price forecast.
Analyzing the SNDX fundamentals
Gross Profit Margin for this corporation currently stands at 0.21% with Operating Profit Margin at -491.51%, Pretax Profit Margin comes in at -448.94%, and Net Profit Margin reading is -448.94%. To continue investigating profitability, this company’s Return on Assets is posted at -0.44, Equity is -0.53 and Total Capital is -0.54. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.40 points at the first support level, and at 20.24 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.17, and for the 2nd resistance point, it is at 23.78.
Ratios To Look Out For
It is important to note that Syndax Pharmaceuticals Inc [NASDAQ:SNDX] has a current ratio of 8.93. On the other hand, the Quick Ratio is 8.93, and the Cash Ratio is 2.26.
Transactions by insiders
Recent insider trading involved Goldan Keith A., Chief Financial Officer, that happened on Jun 14 ’24 when 1250.0 shares were purchased. Director, Morrison Briggs completed a deal on Aug 09 ’23 to sell 52855.0 shares. Meanwhile, Director Meury William sold 83000.0 shares on Aug 02 ’23.
